Abstract
Many advances in small RNA-seq technology and bioinformatics pipelines have been made recently, permitting the discovery of novel miRNAs in the embryonic day 15.5 (E15.5) mouse brain. We aimed to improve miRNA discovery in this tissue to expand our knowledge of the regulatory networks that underpin normal neurodevelopment, find new candidates for neurodevelopmental disorder aetiology, and deepen our understanding of non-coding RNA evolution. A high-quality small RNA-seq dataset of 458 M reads was generated. An unbiased miRNA discovery pipeline identified fifty putative novel miRNAs, six of which were selected for further validation. A combination of conservation analysis and target functional prediction was used to determine the authenticity of novel miRNA candidates. These findings demonstrate that miRNAs remain to be discovered, particularly if they have the features of other small RNA species.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Background
MicroRNAs (miRNAs) are a class of small non-coding RNAs (ncRNAs). Initially discovered in Caenorhabditis elegans in 1993, miRNAs are encoded by genome sequences and transcribed in the same manner as genes [42]. Canonical miRNA biogenesis involves a well-defined series of RNA processing steps, ultimately yielding a mature miRNA of ~ 20–25 nucleotides in length [5]. Complementary base pairing between the miRNA seed sequence, bases 2–8 from the 5′ end, and sequences within the 3′ UTR of the mRNA, enables the RNA Induced Silencing Complex (RISC) associated with the mature miRNA to prevent translation or degradation the mRNA [36]. Unique spatial and temporal expression profiles indicate the importance of miRNAs in developing tissues, including the brain. Neurodevelopment is disrupted when all miRNA activity is deleted via Ago2 knockout [45, 54]. Furthermore, the disruption of specific miRNAs, including miR-9, miR-124, and miR-132, results in developmental brain defects and altered brain function in adults [28, 40, 52, 55, 58]. Thus, the regulation of gene expression by miRNAs is necessary for typical neurodevelopment. The importance of miRNAs in neurodevelopment has been noted by various researchers looking at the origin of neurodevelopmental disorders. Multiple studies have shown that miRNA expression profiles differ between individuals with neurodevelopmental and psychiatric disorders and matched control groups [1, 23, 24, 30], suggesting that miRNA dysregulation is a component of neurodiversity and disease aetiology.
Initial miRNA discovery was achieved using cloning and gel-based methods [41], where small RNAs were isolated from total RNA libraries by size fractionation, used to create cDNA clones, and then subjected to Sanger sequencing to identify putative sequences of small RNAs. A Northern blot would subsequently confirm the expression of an RNA. These early experimental approaches to identify miRNAs were followed by computational prediction strategies in which genome data were scanned for putative miRNA features. Prediction is based on the presence of an open reading frame, proximity to a gene promoter, and predicted thermal stability of a pre-miRNA hairpin [7]. Methods based on high-throughput sequencing have been developed to overcome the limitations of early experimental and computer-based techniques. High-throughput sequencing of small RNAs is followed by specialized bioinformatics tools that determine the probability of a read being a genuine miRNA. Combining experimental and computational strategies at a high-throughput scale, sequencing, and bioinformatics approaches have greatly increased the ability of researchers to detect novel miRNAs [20, 62]. The software miRDeep2 identifies novel miRNAs from small RNA-seq data and reports the probability that each candidate is a genuine miRNA [21]. In brief, small RNA-seq reads were mapped to the reference genome and quantified in comparison to existing miRBase miRNAs. The thermal stability of the predicted pre-miRNA secondary structure was calculated, and a read signature consisting of read counts for the mature miRNA sequence, star sequence, and loop was generated. Each candidate novel miRNA is assigned a score based on these parameters, and the estimated probability of the reported miRNA is genuine. The miRDeep2 workflow is summarized in Fig. 1B. Ongoing novel miRNA discovery has yielded new candidate miRNAs from many cells, tissues, developmental stages, species, and pathologies. Since miRNAs often demonstrate unique spatiotemporal expression patterns, many have been discovered because they are not present in specific contexts [13]. However, specific expression dynamics do not negate their importance; all novel miRNAs contribute to the genetic networks underpinning development, homeostasis, and/or pathological processes. Therefore, it is vital to continue searching for these undiscovered components to improve our understanding of the processes to which they contribute and because they represent potential candidates for novel avenues of research into disease-causing mechanisms [44]. In addition to its biomedical utility, this research can further our understanding of miRNA evolution [6].
This research aimed to update novel miRNA discovery in the developing mouse brain, which has not been investigated in the past decade [44], and could benefit significantly from improvements made over this period in small RNA-seq technology and specialist bioinformatics tools such as miRDeep2. We have assessed the characteristics of six candidate novel miRNAs discovered by the highly stringent miRDeep2 criteria in the E15.5 mouse brain by combining bioinformatics, conservation, expression data and functional prediction; the miRNA attributes that further support those identified candidates are genuine novel miRNAs. E15.5 was selected as the preferred developmental time point for our samples because it is a critical time period for regional identity and brain neurodevelopment, and also because it is the same time point investigated by Ling et al. [44], allowing us to build on their findings. Conservation analysis revealed a mix of results, which can be broadly categorised as highly conserved miRNAs (Novel_3, Novel_11, Novel_16, and Novel_17), potentially conserved miRNA (Novel_1), and potentially species-specific miRNA (Novel_2). RT-qPCR confirmed the expression of Novel_1, 2, 3, 11, 16, and 17 in multiple tissues. Finally, pathway analysis of the predicted target genes revealed potential functions for each candidate miRNA, where many over-represented pathways were involved in neurological processes, the cell cycle, and proliferation. Together, these data support the authenticity of the six candidate novel miRNAs and further indicate the likely validity of other candidates among those discovered in the E15.5 mouse brain.
Methods and materials
Animal husbandry & tissue collection
Breeding and dissection of C57BL/6 wild-type mice was performed with the approval of the University of Otago Animal Ethics Committee to generate embryos at specific developmental time points. The mice were housed in standard conditions with ad libitum access to food and water. A mating pair, a dam and a stud, were housed together for up to four nights and checked each morning for a copulation plug. After the identification of a copulation plug or after four consecutive nights, the dam and stud were separated, and the developmental stage was considered embryonic day 0.5 (E0.5). The dams were culled by cervical dislocation to collect embryos at E15.5. Embryo dissections were performed in cold, sterile 70% PBS to collect whole brain tissue for RNA isolation and gonad tissue to determine the sex of each embryo by the presence (male) or absence (female) of testis cords. In addition to E15.5 brain tissue, E11.5 brains, E15.5 liver and gonads, and the adult spinal cord were collected for RNA extraction.
RNA isolation & purification
Individual brains that had been sexed were kept in 70% sterile PBS on ice for immediate RNA isolation or stored in RNALater (Ambion) at − 20 °C. RNA was extracted using the Purelink RNA miniprep kit (Ambion) following the manufacturer’s instructions, including additional DNase treatment. Manual homogenization was performed with a sterile needle tip before being passed through an 18-gauge syringe and centrifuged for 2 min at 12,000×g. In the final step, RNA was eluted in 50 μL mqH2O and stored at − 20 °C. RNA was purified using ethanol precipitation. The RNA pellet was resuspended in 15 μL mqH2O. The concentration of each sample was measured by using a NanoDrop spectrophotometre. The purity of each sample was analysed using the 260/230 and 260/280 ratios. RNA samples with ratios of 1.8–2.2 were considered of sufficient quality for downstream application.
Novel miRNA discovery
The miRDeep2 tool was used to identify novel miRNAs in a previously generated small RNA-seq dataset consisting of 3 male and 3 female replicates from the E15.5 mouse brain [59]. The mm9 genome was indexed as a reference genome, and mature and precursor miRNA sequences were obtained from the latest version of miRBase (v. 22; [26]. Fastq sequences were processed and quality controlled using FastQC [2], and then all six sample FASTA files (n = 3/sex) were concatenated to pool data and increase read depth. Fasta files were collapsed and run through a series of commands to map the sequences back to the reference genome. First, bwa aln was used to find the coordinates of the input reads and convert fasta files into sai format. Second, bwa samse generated sam alignments for reads from the sai input. Next, the samtools view was used to convert the SAM files into BAM files. Finally, the bam files were converted into the format required by miRDeep2.arf, by bwa_sam_converter. The main miRDeep2.pl script was run on the mapped arf file using the reference genome and known miRNA sequences from miRBase. This script generated a main report summarising novel miRNA discovery, details of every individual miRNA identified, including statistical parameters, and pdf files with RNA secondary structure information on each novel miRNA [21].
Pre-miRNA conservation
UCSC Blat [37] was used to align pre-miRNA sequences to the mm9 genome; the same assembly was used to discover small RNAs, along with a range of genomes from other species. The genomes selected for comparison included rat (another rodent species), human and rhesus monkeys (primates), dogs and cows (placental mammals), and chickens (avian, vertebrate outgroup) from the Multiz alignment. Multiz aligns pairwise Blastz sequences to the reference genome and assigns each region a conservation score. Tracks of other vertebrate sequences in the genome browser provide a specific indication of which individual nucleotides change among vertebrate species [10]. The Phylo-P algorithm track was also used to measure conservation by testing whether each nucleotide in the sequence was substituted at a rate faster or slower than expected from neutral genetic drift [50]. The miRNAs were considered conserved among vertebrates if the average identity between the top four alignments was > 80%. Potential species-specific miRNAs, where pre-miRNA mapped to a poorly conserved region of other vertebrate genomes, were assessed in the UCSC genome browser by aligning all available mouse strains with a cactus analysis, an algorithm such as Multiz [49].
miRNA RT-qPCR
We used the MystiCq microRNA cDNA Synthesis Kit (Sigma) to prepare cDNA. PolyA Tailing and cDNA synthesis reactions were carried out per the manufacturer’s instructions using 1 μg RNA as input, adding 0.5 μL of 5 nM cel-miR-39 spike-in oligo to the PolyA Tailing reaction mix to act as an exogenous reference gene. Negative controls were generated using polyA-tailed RNA that did not contain reverse transcriptase during cDNA synthesis. Next, 1 μL of microRNA cDNA (diluted 1 in 2 in mqH2O) was added to 5 μL SYBR Green MasterMix (ThermoFisher), 0.75 μL each primer, and 2.5 μL mqH2O in a 96-well plate, where the two primers consist of (a) a miRNA-specific forward primer designed in IDT PrimerQuest (Table S1), and (b) a universal reverse primer provided in the MystiCq Kit. The primers were tested for their specificity and efficiency. Each sample was loaded in triplicates. The 96-well plate was loaded into a Viia7 PCR Machine (ThermoFisher) for the RT-qPCR reaction with the following thermal profile: 2 min at 50 °C, 2 min at 95 °C, 40 cycles of 15 s each at 95 °C, 60 °C and 72 °C, followed by a machine-programmed dissociation curve. Expression was normalised to the reference gene cel-miR-39 using the 2−ΔCt method.
miRNA seed sequence family analysis
To test whether novel miRNAs belong to existing miRNA families, the mature sequence of each novel miRNA was input into the miRBase BLASTn search function with no species filter [39]. This search function output is an E-value, which indicates whether sequence similarity is likely to arise because of true sequence homology rather than chance. An E-val < 1 is considered a genuine hit, whereas an increasing E-val suggests that sequence homology is due to chance. The E-value threshold for our analysis was set to 10, and an arbitrary but high threshold was set to identify any low-confidence hits that may have a conserved seed region.
Functional prediction
Firstly, target genes for each candidate novel miRNA were ascertained from two databases with the functionality to enter customized sequences: TargetScan Custom (v.5.2) was used to predict target gene-based complementarity between the seed sequence [22], and miRDB custom prediction was also used, selecting “mouse” as the species [63]. Next, the list of predicted targets from each tool was compared using GeneVenn (http://genevenn.sourceforge.net/) to determine the target genes that were common to both prediction methods, which minimizes the inclusion of false positives. The target gene list for each novel miRNA was then searched using DAVID [16] to determine whether genes in that list were over-represented in any KEGG pathway [34].
Results
Novel miRNA discovery in the embryonic mouse brain
Six small RNA sequencing libraries generated from E15.5 mouse brain tissue (n = 3/sex) were pooled to improve read depth for novel miRNA discovery (GEO: GSE211816; [59]. The combined FASTA file contained 458,470,358 raw reads (Fig. 1A, which, according to the most stringent estimates, is sufficient for novel discoveries (Raabe et al; Sims et al. [62]. miRDeep2 analysis confirmed that this dataset was representative of the E15.5 mouse brain, identifying miRNAs that are highly expressed in the developing mouse brain (Supplementary File1miRDeep2output.pdfx).File 1) The novel discovery module of miRDeep2 predicted 894 candidate miRNAs, 115 reaching the previously determined miRDeep2 score threshold of 4 [17, 31]. The final filtering step required sequences to demonstrate a stable RNA secondary structure, as indicated by a significant randfold calculation. Randfold measures RNA folding using MFE (maximum free energy estimates). In the context of miRNA, randfold refers to the likelihood that the predicted pre-miRNA sequence can fold into a stable RNA secondary structure (Fig. 1D). For example, 50 of 115 candidates met the miRDeep score threshold and were likely to form a stable RNA hairpin (Fig. 1A).
To obtain more information about these 50 putative novel miRNAs, their genomic locations and the DNA strand from which they originated were determined. Of the top 50 novel miRNAs, 22 mapped to introns, 8 to intergenic regions, 6 to LTRs and 4 to promoters, 3 to exons, and 2 to SINEs. One each mapped to 3’UTR, TTS, LINE, scRNA and snRNA (Fig. 1E). This finding is consistent with most known miRNAs being either intronic or intergenic [7].
Validation and spatiotemporal expression of novel miRNAs
RT-qPCR validation was performed on six putative novel miRNAs, selected for the highest ranked miRDeep2 score, and based on a miRDeep2 score > 2 × 102 and mapped to only one location in the mm9 genome (File S1, Fig. 2), allowing the design of specific primers. The expression of each miRNA was profiled in six different tissues.
Novel_1 was the sequence with the highest miRDeep2 score (2800) and a significant randfold score in the small RNA-seq library that did not map to a known miRNA, with a high read count of > 53,000 reads for the mature miRNA (File S1). Expression analysis revealed Novel_1 expression level varied with the tissue type tested (one-way ANOVA; p = 0.0001) (Fig. 2A). The highest relative expression was observed in the neuronal samples (E11.5 and E15.5 brain) and the adult spinal cord. In comparison, there was modest expression in the E15.5 liver and minimal amplification of Novel_1 in the E15.5 gonads. In addition, Novel_1 expression was significantly higher in the brain than in non-neural tissues (liver, p = 0.0014; gonad, p = 0.0003) and the E11.5 brain (Fig. 2A p = 0.012).
Of the novel miRNA candidates identified by miRDeep2, Novel_2 demonstrated one of the highest read counts (> 18,000), in addition to a characteristic read distribution and pre-miRNA hairpin (Fig. 2B; File S1). Novel_2 expression was detectable, although it varied greatly between biological replicates, and there was no significant difference in the means between tissues (one-way ANOVA; p = 0.29).
Novel_3 was an abundant transcript with characteristic hairpin and miRNA signature characteristics (Fig. 2C). Novel_3 miRNA expression was significantly different between tissues (one-way ANOVA; p < 0.0001). Its expression was significantly higher in the E15.5 liver than in all other tissues assayed (Fig. 2C; p < 0.0001). However, relative expression was modest in the brain at E11.5 and E15.5, and it was detectable in the adult spinal cord and E15.5 gonads (Fig. 2C).
Novel_11 fits the criteria for miRDeep2 pre-miRNA hairpin formation and miRNA signatures (Fig. 2D). The coordinates for Novel_11 in the mm9 genome are located within an intron of nucleolar protein 4-like (8430427H17Rik) gene. Amplification was detected across all assayed tissues for Novel_11, however, there was no significant differences in expression across tissues. Expression was higher in the gonad for two of the biological replicates (Fig. 2D), this was not consistent and was not dependent on gonadal sex (data not shown).
Novel_16 demonstrated characteristic hairpin stability and read coverage signature of a mature miRNA (Fig. 2E). Alignment to mm9 shows that Novel_16 is located near Empty Spiracles Homeobox 2 (Emx2), a gene that aids in determining the rostral-caudal patterning of the developing neocortex [9]. Novel_16 was also enriched in E15.5 gonads compared to all other tissues (p < 0.0001). Modest Novel_16 expression was detected in the assayed embryonic brain tissues, and there was a significant difference in expression based on tissue type (one-way ANOVA; p = 028) (Fig. 2E).
Novel_17 maps to chromosome 17, within the intron of the Wdr43 (WD40 repeat 43) gene, which codes for an RNA-binding protein [8]. It was predicted to form a stable pre-miRNA hairpin, with an miRDeep2 score of 240, and a typical miRNA read distribution with a modest read count of 403 for the mature miRNA (Fig. 2F; File S1). There were no statistically significant differences in expression between groups (Tukey’s multiple comparison test, p > 0.05). The E15.5 brain showed consistent expression of Novel_17 between biological replicates, and the relative expression in other tissues was very variable (Fig. 2F).
Predicting candidate miRNA function
A measure of miRNA functionality can be obtained by investigating the relationships between novel miRNA sequences and existing miRNAs and miRNA families. miRNA families are defined by similarities in structure and function, particularly in seed sequences, because they are derived from common ancestral sequences [33]. A novel miRNA that shares a seed sequence with an existing miRNA family indicates shared functionality and helps to validate putative novel miRNAs. Functional prediction was performed via pathway analysis of the predicted target genes to infer the possible function of each novel miRNA. The full results for target prediction and functional enrichment analysis can be found in Supplementary Data File S4.
Novel_1 seed sequence in miRBase found no hits (E-val < 1); therefore, it is not a member of any known miRNA family. The 47 Novel_1 predicted mRNA targets were significantly associated with biological processes primarily related to metabolism and development (Fig. 3A; File S4). Three Novel_1 predicted targets were linked to the ErbB signalling pathway (KEGG ID: 04012; p = 0.038). ErbB signalling is vital for forming neural circuitry and has been implicated in neuropsychiatric disorder pathology (Brinkman et al., Mei et al.). A particularly interesting target gene is Dcx (Doublecortin), which is required for normal migration of neurons in cortical development and mutated in the brain disorder lissencephaly [35]. As Novel_1 appears to target genes and pathways critical to neurodevelopment, Novel_1 expression may influence crucial processes in the embryonic mouse brain.
The Novel_2 seed comparison identified two mammalian miRNAs with similar seed sequences. However, both had E-value BLAST score of > 1, suggesting the similarity could be due to chance rather than an evolutionary relationship. TargetScan and miRDB identified 36 overlapping target genes of Novel_2 (Fig. 3B and File S4). GO analysis revealed an over-representation of terms related to vascular and embryonic development (Fig. 3B and File S4). Targets of note included cell-cycle-related Cnnm2 (cyclin M2), growth factor receptor Fgfr1 (fibroblast growth factor receptor 1), oncogene-related Rassf1 (Ras association domain family member 1), and Rxra (Retinoid X Receptor A). These targets suggest that Novel_2 may have a role in regulating cell growth and proliferation in the developing brain.
For Novel_3, seed sequence analysis revealed no evidence for shared similarity with known vertebrate miRNAs (Fig. 3C). Only 30 predicted target mRNAs overlapped between TargetScan and miRDB (Fig. 3C). However, GO analysis still found significant enrichment for metabolic processes, signal transduction and developmental processes (Fig. 3C, File S4). Some of these genes themselves are of interest in brain development specifically, Nipa2 (non-imprinted in Prader-Willi/Angelman syndrome 2), Sez6 (seizure-related 6 homologs), and Aff4 (AF4/FMR2 family member 4) are involved in neurodevelopmental disorders with complex phenotypes [12, 32, 47, 48, 64]. These findings suggest that Novel_3 could be linked to the genetic regulatory circuits that underlie neurodevelopment.
The Novel_11 seed also showed high similarity to miR-324-3p, with significant hits (E-value < 1) in nine species (Fig. 3D). This suggests that Novel_11 is a previously unidentified member of the miR-324 family. The function of miR-324 function has been described in mouse brain development, with established functions in astrocyte-mediated synaptogenesis and subsequent effects on neuronal function and excitability [29, 57]. Functional prediction yielded a pool of 261 putative target genes, including several with notably brain-related functions: Nav1 (neuron navigator 1), Myt1l (myelin transcription factor 1-like), Syde1 (synapse defective 1 Rho GTPase homolog 1), Htt (Huntingtin) and Ndel1 (nudE neurodevelopment protein 1 like 1). Other target genes of note are associated with neuronal physiology (Grin1, Cacnb1, and Cacna1c) and cell cycle regulation (Cdk6, Cdca4, and Caprin1). Finally, genes such as Mecp2 (methyl CpG binding protein 2) and Nufip2 (nuclear fragile X mental retardation protein interacting protein 2) are essential for normal neurodevelopment [4, 25]. GO analysis revealed many enriched terms among Novel_11 target mRNAs. Many of the most significant hits related to development (“multicellular organism development”) included nervous system development (GO: 0007399) (Fig. 3D, File S4). Based on the target gene prediction, Novel_11 may influence a range of genes involved in mouse brain development.
Novel_16 is not a member of any known miRNA family, as the miRNA family analysis yielded no significant BLAST alignment (E-value < 1; Fig. 3E). Target prediction identified 56 overlapping potential mRNAs for Novel_16. Genes with roles in neurodevelopment were consistent among the target mRNAs (Aff4, Nras, Hap1, Dcx) (File S3). Overrepresented GO terms included “positive regulation of cell proliferation” and “vesicle transport along microtubules”. Thus, Novel_16 has the potential to regulate processes essential for neurodevelopment and neuronal function.
For Novel_17, miRNA family analysis found hits with the seed sequences of 7/9 members of the miR-282 family (Fig. 3F). This finding suggests that Novel_17 diverged from an ancestor of the miR-282 family or, based on the low E-val reported, that seed sequence similarity emerged by chance. We identified 73 predicted targets for Novel_17 (Fig. 3F, File S3). The top significant GO term significantly overrepresented was “nervous system development (GO: 0007399); other terms were mostly related to developmental biology (Fig. 3F, File S4). Individual target genes reflect a potential role for Novel_17 in developmental processes. Cell cycle functions (Cdk6, Cdc27, Cdc23), developmental pathways (Tgfbr2) and neurodevelopment-related genes (Cbln2, Syt9) all provide potential mechanistic bases for Novel_17 to impact mouse brain development.
Variable conservation among novel miRNAs
Conservation analysis was performed for the six candidate miRNAs to determine whether each sequence was unique to mice or present in other species (Fig. 4).
The pre-Novel_1 sequence has 100% identity in mouse and rat genomes but does not match the sequences of other vertebrate genomes. The phylo-P algorithm gives a primarily positive score throughout the sequence, which is likely driven by rat conservation. Conservation analyses suggested that Novel_1 is probably a rodent-specific miRNA (Fig. 4A & 5A).
Although the pre-Novel_2 sequence failed to align with any other vertebrate genomes, it aligned with > 99% identity with other mouse strains (Fig. S5). Therefore, Novel_2 is potentially a recently emerged mouse-specific miRNA (Fig. 5A).
Pre-Novel _3 is located within an intron of the lncRNA growth arrest-specific transcript 5 (Gas5) gene, a lncRNA tumour suppressor [19] (Fig. 4B). Gas5 notably hosts several other small RNAs within its introns [56]. Pre-Novel _3 identity was ~ 80% among all vertebrates and has a positive phylo-p score, indicating slower evolution than expected, which is consistent with sequence conservation. Furthermore, the mature miRNA and seed sequences are increasingly retained in closely related species, suggesting a functional miRNA in many mammals that may be a conserved aspect of the Gas5 locus (Fig. 5A).
Pre-Novel_11 had a positive phylo-p score, which indicates a slower evolution than expected. This is consistent with the sequence conservation and demonstrates approximately 87.5% identity among vertebrates (Fig. S5). While the seed sequence showed 100% conservation in rat, human, rhesus, and cow genomes, unique indels in the seed regions of both dog and avian outgroups likely rendered non-functional in those species (Fig. S5). Therefore, Novel_11 may be a miRNA in mammalian species (Fig. 5A).
Pre-Novel_16 is generally highly conserved among mammals, averaging ~ 80% identity, but no alignment to the avian genome. Conservation of the mature Novel_16 sequence is also high among mammalian genomes (Fig. 4C). However, there was greater variability in the phylo-p score throughout the precursor sequence (Fig. 4C). This may be attributable to an 8 bp insertion in the predicted passenger strand of the primate sequence (Fig. 4C). These findings suggest that Novel_16 is a functional miRNA in non-primate mammals (Fig. 5A).
Novel_17 conservation analysis indicated ~ 94% pre-miRNA sequence identity between all mammalian species and 100% seed sequence identity between all mammals, with no alignment with the avian genome (Fig. 4D & 5B). While the positive phylo-p score indicates slower evolution than expected, consistent with sequence conservation, there seems to be some divergence between rodent species: the rat sequence shows only 87.21% identity, making it the most different from mouse and other mammalian species (Fig. 4D & 5B). This suggests that Novel_17 is likely a functional miRNA in mammals, but its sequence has diverged in the rat (Fig. 5A).
Discussion
Using robust small RNA-seq datasets generated from the E15.5 mouse brain, an unbiased miRNA discovery strategy identified 50 putative novel miRNAs, six of which were further validated. In addition, a combination of conservation analysis and mRNA target prediction was used to determine the authenticity of the six miRNA candidates. These findings demonstrate that miRNAs tend to remain undiscovered if they are derived from other RNA (ncRNA).
Conservation and function of candidate novel miRNAs
The novel miRNAs identified here were previously undiscovered components of the instruction manual for mouse brain development. Genomic networks that inform the processes of neurodevelopment are enormously complex. Given this overall complexity, exploring the role of any individual miRNA, especially one that has been discovered to date, could be dismissed as of little importance. However, subtle changes underscore much of the typical and pathological variations seen in the brain, often as additional components of networks that ensure robust phenotypes that buffer differences in gene expression or the environment [14, 51]. Together with the predicted conservation of several candidate novel miRNAs in humans (Novel_3, Novel_11, Novel_17), these novel miRNAs represent candidates whose functions are required for neurodevelopment and whose dysfunction contributes to neurodevelopmental disorders. In contrast, the other validated candidates did not appear to be conserved in humans, suggesting that these sequences are either non-functional or rodent-specific. However, their function is still worth studying to improve our understanding of the commonly used mouse model and for an evolutionary perspective on why they have not been retained in humans.
Dual small RNA function
Three validated miRNAs map to known ncRNAs in the mouse genome: Novel_1 aligns with Rny1, Novel_3 to Snord79, and Novel_17 to Snord_92. One would initially assume these are false positives, mistakenly identified by the miRDeep2 algorithm due to shared features between different ncRNA classes, such as read length and stable secondary structure formation [11]. However, these candidates should not be discounted; multiple publications have previously encountered instances where a single ncRNA transcript may perform the function of a snoRNA, for example, in addition to generating a mature miRNA. Four pieces of evidence support this phenomenon, known as dual RNA function: (1) ~ 22nt sequences derived from snoRNAs associate with Ago proteins, meaning they guide downregulation of target mRNA via the RISC complex [18]; (2) snoRNA-derived fragments are Dicer-dependent, thereby sharing a critical step in biogenesis with pre-miRNAs [60]; and (3) reads derived from snoRNAs showed a high abundance of one stem, with lower abundance for its complementary stem and the loop [18]. This non-random degradation pattern is consistent with the typical miRNA signature but atypical for snoRNAs. Additionally, (4) small RNAs derived from snoRNA can silence target genes in luciferase reporter assays [11]. The possibility of dual RNA function might explain the three mentioned examples where a candidate novel miRNA overlaps with a known ncRNA.
Novel_3 and Novel_17 both mapped to snoRNAs. Whether they could function as novel miRNAs, in addition to their previously described function, depends on whether they can demonstrate any of the four characteristics outlined above. The data presented here cannot confirm the downregulation of any target genes or Dicer-dependence. The small terminal loop size observed for Novel_3 and Novel_17 compared to the canonical terminal loop size suggests Dicer-independent biogenesis of an atypical precursor via non-canonical processing [27]. In contrast, both candidate novel miRNAs demonstrated a typical miRNA signature consisting of an abundant mature sequence compared with low expression of star and loop sequences.
It has also been suggested that miRNAs can be derived from Y-RNAs, a group of small RNA that associate with Ro-proteins to form ribonucleoproteins (RNPs) [43]. This claim is based on structural similarities with miRNA precursors [61]. However, it has not been confirmed that small sequences derived from Y-RNAs downregulate target gene expression [46]. Without evidence that they function as miRNAs or show arm-specific stabilisation/degradation patterns expected of miRNAs [53], there remains uncertainty regarding whether functional miRNAs can be derived from Y-RNAs. Whether Novel_1 is a mature miRNA derived from Rny1 is conflicting. First, the predicted secondary structure of pre-Novel_1 was similar to that of typical Y-RNA features, including a bulged cytosine ([38]. In contrast, Novel_1 shows a miRNA read signature with the preferential stability of one stem strand. Further experiments are required to determine whether Novel_1 has a Y-RNA function via interaction with Ro-proteins, miRNA function, interaction with RISC components, downregulation of target genes, or both.
This highlights the possibility that novel miRNA candidates that map to known ncRNAs should not be immediately discarded as false positives. Although these claims are limited without further functional assays, up to three top candidates can demonstrate dual functions of small RNA. These examples provide an emerging body of evidence regarding the complex and diverse roles of ncRNAs. Indeed, excluding candidates on this basis presumably underlies why these RNAs have escaped discovery and continues to keep other miRNAs undiscovered.
Limitations and future directions
A vital advantage of the novel miRNA discovery strategies utilized here is the consideration of multiple types of evidence (bioinformatics prediction, conservation, expression, and functional prediction) to predict whether a small RNA transcript is a candidate novel miRNA. However, to ensure that each candidate is a genuine novel miRNA, further experiments should be performed to distinguish it from other RNA species and determine their function; the former is particularly important given the potential for dual small RNA function. For example, in vitro knockdown by antagomiRs could help to reveal the role of each novel miRNA. Target pull-down methods can also be used to identify specific miRNA target interactions in vivo [3, 15].
In addition to confirming that each candidate carries out fundamental miRNA function and downregulation of target genes, we also wanted to distinguish these sequences from other ncRNA species, many of which share the characteristic features of miRNAs. This could be achieved by exploiting the characteristics that differ between each RNA species, yet the possibility of dual small RNA function complicates it. Transcripts that fit the criteria for more than one RNA category force our understanding of these categories to transcend the disparate classical grouping into a more fluid sense of complex RNA functions. A general approach requires experiments to confirm each type of predicted function. In addition to demonstrating the downregulation of target genes as per miRNA function, characteristics unique to snoRNAs/Y-RNAs/etc. must be confirmed. Such a challenging experimental design has so far resulted in very few efforts being made to tease apart dual RNA functions.
A notable strength of our novel miRNA discovery strategy is the intentional sample inclusion from E15.5 brains of both sexes. Other studies, including our own (Szakats et al., manuscript in review), have shown sex-based differences in miRNA expression in the developing mouse brain. To account for any novel miRNAs that may be differentially expressed between the sexes, we ensured that tissue samples from both sexes were included. Failure to report the sex of samples is a common flaw in many previous studies, as it may result in false negatives in the scenario where a miRNA is highly expressed in females but not males, yet only males are sampled in the study, or vice versa. Increased recognition of sex-biased genes and miRNA expression should improve the use of this strategy to include both sexes in the study design, resulting in novel discoveries that were previously missed.
Conclusion
We have presented the first novel miRNA discovery experiment conducted in the embryonic mouse brain over the last decade. Improvements in bioinformatics discovery tools in the intervening years and the very high read depth that we obtained contributed to generating a highly powered dataset. We identified 50 and further validated six putative miRNAs from these data, which have not been previously reported. Bioinformatics prediction, sequence conservation, temporal expression, and functional prediction provide crucial evidence. Combining several types of evidence suggests that the ten candidate miRNAs investigated are genuine novel miRNAs. The discovery and successful validation of new miRNAs augments our current understanding of ncRNA regulation in mouse brain development and provides new avenues to explore this complex process. Moreover, we have provided compelling recent examples of dual small RNA function. This intriguing phenomenon has only been validated on a handful of occasions and, with the additional evidence presented here, may generate a thought-provoking discussion regarding the delineation of RNA species.
Data availability
Enquiries about data availability should be directed to the authors.
References
Abu-Elneel K, Liu T, Gazzaniga FS, Nishimura Y, Wall DP, Geschwind DH, Lao K, Kosik KS (2008) Heterogeneous dysregulation of microRNAs across the autism spectrum. Neurogenetics 9(3):153–161. https://doi.org/10.1007/s10048-008-0133-5
Andrews, S. (2010). FastQC: A quality control tool for high throughput sequence data. http://www.bioinformatics.babraham.ac.uk/projects/fastqc/
Awan HM, Shah A, Rashid F, Wei S, Chen L, Shan G (2018) Comparing two approaches of miR-34a target identification, biotinylated-miRNA pulldown vs miRNA overexpression. RNA Biol 15(1):55–61. https://doi.org/10.1080/15476286.2017.1391441
Bardoni B, Castets M, Huot ME, Schenck A, Adinolfi S, Corbin F, Pastore A, Khandjian EW, Mandel JL (2003) 82-FIP, a novel FMRP (fragile X mental retardation protein) interacting protein, shows a cell cycle-dependent intracellular localization. Hum Mol Genet 12(14):1689–1698. https://doi.org/10.1093/hmg/ddg181
Bartel DP (2018) Metazoan MicroRNAs. Cell 173(1):20–51. https://doi.org/10.1016/j.cell.2018.03.006
Berezikov E (2011) Evolution of microRNA diversity and regulation in animals. Nat Rev Genet 12(12):846–860. https://doi.org/10.1038/nrg3079
Berezikov E, Cuppen E, Plasterk RH (2006) Approaches to microRNA discovery. Nat Genet 38(Suppl):S2-7. https://doi.org/10.1038/ng1794
Bi X, Xu Y, Li T, Li X, Li W, Shao W, Wang K, Zhan G, Wu Z, Liu W, Lu JY, Wang L, Zhao J, Wu J, Na J, Li G, Li P, Shen X (2019) RNA targets ribogenesis factor WDR43 to chromatin for transcription and pluripotency control. Mol Cell 75(1):102–116. https://doi.org/10.1016/j.molcel.2019.05.007
Bishop KM, Garel S, Nakagawa Y, Rubenstein JL, O’Leary DD (2003) Emx1 and Emx2 cooperate to regulate cortical size, lamination, neuronal differentiation, development of cortical efferents, and thalamocortical pathfinding. J Comp Neurol 457(4):345–360. https://doi.org/10.1002/cne.10549
Blanchette M, Kent WJ, Riemer C, Elnitski L, Smit AF, Roskin KM, Baertsch R, Rosenbloom K, Clawson H, Green ED, Haussler D, Miller W (2004) Aligning multiple genomic sequences with the threaded blockset aligner. Genome Res 14(4):708–715. https://doi.org/10.1101/gr.1933104
Brameier M, Herwig A, Reinhardt R, Walter L, Gruber J (2011) Human box C/D snoRNAs with miRNA like functions: expanding the range of regulatory RNAs. Nucleic Acids Res 39(2):675–686. https://doi.org/10.1093/nar/gkq776
Chapman NH, Nato AQ Jr, Bernier R, Ankenman K, Sohi H, Munson J, Patowary A, Archer M, Blue EM, Webb SJ, Coon H, Raskind WH, Brkanac Z, Wijsman EM (2015) Whole exome sequencing in extended families with autism spectrum disorder implicates four candidate genes. Hum Genet 134(10):1055–1068. https://doi.org/10.1007/s00439-015-1585-y
Chen W, Qin C (2015) General hallmarks of microRNAs in brain evolution and development. RNA Biol 12(7):701–708. https://doi.org/10.1080/15476286.2015.1048954
Chen Y, Shen Y, Lin P, Tong D, Zhao Y, Allesina S, Shen X, Wu CI (2019) Gene regulatory network stabilized by pervasive weak repressions: microRNA functions revealed by the May-Wigner theory. Natl Sci Rev 6(6):1176–1188. https://doi.org/10.1093/nsr/nwz076
Dash S, Balasubramaniam M, Dash C, Pandhare J (2018) Biotin-based pulldown assay to validate mRNA targets of cellular miRNAs. J Vis Exp. https://doi.org/10.3791/57786
Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA (2003) DAVID: database for annotation, visualization, and integrated discovery. Genome Biol. https://doi.org/10.1186/gb-2003-4-9-r60
Dhahbi JM, Atamna H, Boffelli D, Magis W, Spindler SR, Martin DI (2011) Deep sequencing reveals novel microRNAs and regulation of microRNA expression during cell senescence. PLoS ONE 6(5):e20509. https://doi.org/10.1371/journal.pone.0020509
Ender C, Krek A, Friedlander MR, Beitzinger M, Weinmann L, Chen W, Pfeffer S, Rajewsky N, Meister G (2008) A human snoRNA with microRNA-like functions. Mol Cell 32(4):519–528. https://doi.org/10.1016/j.molcel.2008.10.017
Filippova EA, Fridman MV, Burdennyy AM, Loginov VI, Pronina IV, Lukina SS, Dmitriev AA, Braga EA (2021) Long noncoding RNA GAS5 in breast cancer: epigenetic mechanisms and biological functions. Int J Mol Sci 22(13):6810. https://doi.org/10.3390/ijms22136810
Friedlander MR, Chen W, Adamidi C, Maaskola J, Einspanier R, Knespel S, Rajewsky N (2008) Discovering microRNAs from deep sequencing data using miRDeep. Nat Biotechnol 26(4):407–415. https://doi.org/10.1038/nbt1394
Friedlander MR, Mackowiak SD, Li N, Chen W, Rajewsky N (2012) miRDeep2 accurately identifies known and hundreds of novel microRNA genes in seven animal clades. Nucleic Acids Res 40(1):37–52. https://doi.org/10.1093/nar/gkr688
Friedman RC, Farh KK, Burge CB, Bartel DP (2009) Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19(1):92–105. https://doi.org/10.1101/gr.082701.108
Frye RE, Rose S, McCullough S, Bennuri SC, Porter-Gill PA, Dweep H, Gill PS (2021) MicroRNA expression profiles in autism spectrum disorder: role for miR-181 in immunomodulation. J Pers Med 11(9):922. https://doi.org/10.3390/jpm11090922
Geaghan M, Cairns MJ (2015) MicroRNA and posttranscriptional dysregulation in psychiatry. Biol Psychiatry 78(4):231–239. https://doi.org/10.1016/j.biopsych.2014.12.009
Gonzales ML, LaSalle JM (2010) The role of MeCP2 in brain development and neurodevelopmental disorders. Curr Psychiatry Rep 12(2):127–134. https://doi.org/10.1007/s11920-010-0097-7
Griffiths-Jones S (2010) miRBase: microRNA sequences and annotation. Curr Protoc Bioinform. https://doi.org/10.1002/0471250953.bi1209s29
Han J, Lee Y, Yeom KH, Nam JW, Heo I, Rhee JK, Sohn SY, Cho Y, Zhang BT, Kim VN (2006) Molecular basis for the recognition of primary microRNAs by the Drosha-DGCR8 complex. Cell 125(5):887–901. https://doi.org/10.1016/j.cell.2006.03.043
Hansen KF, Sakamoto K, Aten S, Price KH, Loeser J, Hesse AM, Page CE, Pelz C, Arthur JS, Impey S, Obrietan K (2016) Targeted deletion of miR-132/-212 impairs memory and alters the hippocampal transcriptome. Learn Mem 23(2):61–71. https://doi.org/10.1101/lm.039578.115
Hayman DJ, Modebadze T, Charlton S, Cheung K, Soul J, Lin H, Hao Y, Miles CG, Tsompani D, Jackson RM, Briggs MD, Pirog KA, Clark IM, Barter MJ, Clowry GJ, LeBeau FEN, Young DA (2021) Increased hippocampal excitability in miR-324-null mice. Sci Rep 11(1):10452. https://doi.org/10.1038/s41598-021-89874-1
Hu Y, Ehli EA, Boomsma DI (2017) MicroRNAs as biomarkers for psychiatric disorders with a focus on autism spectrum disorder: current progress in genetic association studies, expression profiling, and translational research. Autism Res 10(7):1184–1203. https://doi.org/10.1002/aur.1789
Ikeda KT, Hirose Y, Hiraoka K, Noro E, Fujishima K, Tomita M, Kanai A (2015) Identification, expression, and molecular evolution of microRNAs in the “living fossil” Triops cancriformis (tadpole shrimp). RNA 21(2):230–242. https://doi.org/10.1261/rna.045799.114
Izumi K, Nakato R, Zhang Z, Edmondson AC, Noon S, Dulik MC, Rajagopalan R, Venditti CP, Gripp K, Samanich J, Zackai EH, Deardorff MA, Clark D, Allen JL, Dorsett D, Misulovin Z, Komata M, Bando M, Kaur M, Krantz ID (2015) Germline gain-of-function mutations in AFF4 cause a developmental syndrome functionally linking the super elongation complex and cohesin. Nat Genet 47(4):338–344. https://doi.org/10.1038/ng.3229
Kaczkowski B, Torarinsson E, Reiche K, Havgaard JH, Stadler PF, Gorodkin J (2009) Structural profiles of human miRNA families from pairwise clustering. Bioinformatics 25(3):291–294. https://doi.org/10.1093/bioinformatics/btn628
Kanehisa M, Sato Y (2020) KEGG Mapper for inferring cellular functions from protein sequences. Protein Sci 29(1):28–35. https://doi.org/10.1002/pro.3711
Kato M, Dobyns WB (2003) Lissencephaly and the molecular basis of neuronal migration. Hum Mol Genet. https://doi.org/10.1093/hmg/ddg086
Kawamata T, Tomari Y (2010) Making RISC. Trends Biochem Sci 35(7):368–376. https://doi.org/10.1016/j.tibs.2010.03.009
Kent WJ (2002) BLAT–the BLAST-like alignment tool. Genome Res 12(4):656–664. https://doi.org/10.1101/gr.229202
Kohn M, Pazaitis N, Huttelmaier S (2013) Why YRNAs? About versatile RNAs and their functions. Biomolecules 3(1):143–156. https://doi.org/10.3390/biom3010143
Kozomara A, Griffiths-Jones S (2011) miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res. https://doi.org/10.1093/nar/gkq1027
Kozuka T, Omori Y, Watanabe S, Tarusawa E, Yamamoto H, Chaya T, Furuhashi M, Morita M, Sato T, Hirose S, Ohkawa Y, Yoshimura Y, Hikida T, Furukawa T (2019) miR-124 dosage regulates prefrontal cortex function by dopaminergic modulation. Sci Rep 9(1):3445. https://doi.org/10.1038/s41598-019-38910-2
Lee RC, Ambros V (2001) An extensive class of small RNAs in Caenorhabditis elegans. Science 294(5543):862–864. https://doi.org/10.1126/science.1065329
Lee RC, Feinbaum RL, Ambros V (1993) The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75(5):843–854. https://doi.org/10.1016/0092-8674(93)90529-y
Lerner MR, Boyle JA, Hardin JA, Steitz JA (1981) Two novel classes of small ribonucleoproteins detected by antibodies associated with lupus erythematosus. Science 211(4480):400–402. https://doi.org/10.1126/science.6164096
Ling KH, Brautigan PJ, Hahn CN, Daish T, Rayner JR, Cheah PS, Raison JM, Piltz S, Mann JR, Mattiske DM, Thomas PQ, Adelson DL, Scott HS (2011) Deep sequencing analysis of the developing mouse brain reveals a novel microRNA. BMC Genomics 12:176. https://doi.org/10.1186/1471-2164-12-176
Liu J, Carmell MA, Rivas FV, Marsden CG, Thomson JM, Song JJ, Hammond SM, Joshua-Tor L, Hannon GJ (2004) Argonaute2 is the catalytic engine of mammalian RNAi. Science 305(5689):1437–1441. https://doi.org/10.1126/science.1102513
Meiri E, Levy A, Benjamin H, Ben-David M, Cohen L, Dov A, Dromi N, Elyakim E, Yerushalmi N, Zion O, Lithwick-Yanai G, Sitbon E (2010) Discovery of microRNAs and other small RNAs in solid tumors. Nucleic Acids Res 38(18):6234–6246. https://doi.org/10.1093/nar/gkq376
Melko M, Douguet D, Bensaid M, Zongaro S, Verheggen C, Gecz J, Bardoni B (2011) Functional characterization of the AFF (AF4/FMR2) family of RNA-binding proteins: insights into the molecular pathology of FRAXE intellectual disability. Hum Mol Genet 20(10):1873–1885. https://doi.org/10.1093/hmg/ddr069
Mulley JC, Iona X, Hodgson B, Heron SE, Berkovic SF, Scheffer IE, Dibbens LM (2011) The role of seizure-related SEZ6 as a susceptibility gene in febrile seizures. Neurol Res Int 2011:917565. https://doi.org/10.1155/2011/917565
Paten B, Earl D, Nguyen N, Diekhans M, Zerbino D, Haussler D (2011) Cactus: algorithms for genome multiple sequence alignment. Genome Res 21(9):1512–1528. https://doi.org/10.1101/gr.123356.111
Pollard KS, Hubisz MJ, Rosenbloom KR, Siepel A (2010) Detection of nonneutral substitution rates on mammalian phylogenies. Genome Res 20(1):110–121. https://doi.org/10.1101/gr.097857.109
Posadas DM, Carthew RW (2014) MicroRNAs and their roles in developmental canalization. Curr Opin Genet Dev 27:1–6. https://doi.org/10.1016/j.gde.2014.03.005
Qian Y, Song J, Ouyang Y, Han Q, Chen W, Zhao X, Xie Y, Chen Y, Yuan W, Fan C (2017) Advances in roles of miR-132 in the nervous system. Front Pharmacol 8:770. https://doi.org/10.3389/fphar.2017.00770
Rutjes SA, van der Heijden A, Utz PJ, van Venrooij WJ, Pruijn GJ (1999) Rapid nucleolytic degradation of the small cytoplasmic Y RNAs during Apoptosis. J Biol Chem 274(35):24799–24807. https://doi.org/10.1074/jbc.274.35.24799
Schaefer A, Im HI, Veno MT, Fowler CD, Min A, Intrator A, Kjems J, Kenny PJ, O’Carroll D, Greengard P (2010) Argonaute 2 in dopamine 2 receptor-expressing neurons regulates cocaine addiction. J Exp Med 207(9):1843–1851. https://doi.org/10.1084/jem.20100451
Shibata M, Nakao H, Kiyonari H, Abe T, Aizawa S (2011) MicroRNA-9 regulates neurogenesis in mouse telencephalon by targeting multiple transcription factors. J Neurosci 31(9):3407–3422. https://doi.org/10.1523/JNEUROSCI.5085-10.2011
Smith CM, Steitz JA (1998) Classification of gas5 as a multi-small-nucleolar-RNA (snoRNA) host gene and a member of the 5′-terminal oligopyrimidine gene family reveals common features of snoRNA host genes. Mol Cell Biol 18(12):6897–6909. https://doi.org/10.1128/MCB.18.12.6897
Sun C, Zhu L, Ma R, Ren J, Wang J, Gao S, Yang D, Ning K, Ling B, Lu B, Chen X, Xu J (2019) Astrocytic miR-324-5p is essential for synaptic formation by suppressing the secretion of CCL5 from astrocytes. Cell Death Dis 10(2):141. https://doi.org/10.1038/s41419-019-1329-3
Sun E, Shi Y (2015) MicroRNAs: small molecules with big roles in neurodevelopment and diseases. Exp Neurol 268:46–53. https://doi.org/10.1016/j.expneurol.2014.08.005
Szakats S, McAtamney A, Cross H, Wilson MJ (2022) Sex-biased gene and microRNA expression in the developing mouse brain is associated with neurodevelopmental functions and neurological phenotypes. Res Square Preprint. https://doi.org/10.21203/rs.3.rs-2121607/v1
Taft RJ, Glazov EA, Lassmann T, Hayashizaki Y, Carninci P, Mattick JS (2009) Small RNAs derived from snoRNAs. RNA 15(7):1233–1240. https://doi.org/10.1261/rna.1528909
Verhagen AP, Pruijn GJ (2011) Are the Ro RNP-associated Y RNAs concealing microRNAs? Y RNA-derived miRNAs may be involved in autoimmunity. BioEssays 33(9):674–682. https://doi.org/10.1002/bies.201100048
Wake C, Labadorf A, Dumitriu A, Hoss AG, Bregu J, Albrecht KH, DeStefano AL, Myers RH (2016) Novel microRNA discovery using small RNA sequencing in post-mortem human brain. BMC Genomics 17(1):776. https://doi.org/10.1186/s12864-016-3114-3
Wong N, Wang X (2015) miRDB: an online resource for microRNA target prediction and functional annotations. Nucleic Acids Res. https://doi.org/10.1093/nar/gku1104
Xie H, Zhang Y, Zhang P, Wang J, Wu Y, Wu X, Netoff T, Jiang Y (2014) Functional study of NIPA2 mutations identified from the patients with childhood absence epilepsy. PLoS ONE 9(10):e109749. https://doi.org/10.1371/journal.pone.0109749
Acknowledgements
We thank Hugh Cross for assistance with establishing the miRDeep2 pipeline.
Funding
Open Access funding enabled and organized by CAUL and its Member Institutions. This work was supported by a School of Biomedical Sciences, Deans Bequest Grant. S.S. was supported by a University of Otago Doctoral Scholarship.
Author information
Authors and Affiliations
Contributions
SS conducted small RNA-seq and novel miRNA discovery and prepared the manuscript. AM performed RT-qPCR and conservation analyses. MW assisted with the experimental design and bioinformatics, supervision of AM and SS, and manuscript revision.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethical approval
Animal work was performed with approval from the University of Otago Ethics Committee.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Szakats, S., McAtamney, A. & Wilson, M.J. Identification of novel microRNAs in the embryonic mouse brain using deep sequencing. Mol Cell Biochem 479, 297–311 (2024). https://doi.org/10.1007/s11010-023-04730-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-023-04730-2